Effects of transforming growth factor-beta 1 (TGF-β1) on in vitro mineralization of human osteoblasts on implant materials
- 31 May 2003
- journal article
- Published by Elsevier in Biomaterials
- Vol. 24 (12), 2013-2020
- https://doi.org/10.1016/s0142-9612(02)00616-6
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Expression of Bone Morphogenetic Proteins by Osteoinductive and Non-osteoinductive Human Osteosarcoma CellsJournal of Dental Research, 1996
- Transforming growth factor‐β1 enhances bone healing to unloaded tricalcium phosphate coated implants: An experimental study in dogsJournal of Orthopaedic Research, 1996
- Systemic administration of transforming growth factor-beta 2 prevents the impaired bone formation and osteopenia induced by unloading in rats.Journal of Clinical Investigation, 1995
- Relationship between actions of transforming growth factor (TGF)‐β and cell surface expression of its receptors in clonal osteoblastic cellsJournal of Cellular Physiology, 1995
- Clinical potential for TGF-βThe Lancet, 1994
- Controlled release of TGF-β1 from a biodegradable matrix for bone regenerationJournal of Biomaterials Science, Polymer Edition, 1994
- Local injection of TGF-β increases the strength of tibial fractures in the ratActa Orthopaedica, 1994
- Bone morphogenetic protein-2b stimulation of growth and osteogenic phenotypes in rat osteoblast-like cells: Comparison with TGF-β1Journal of Bone and Mineral Research, 1991
- Stimulation of bone formation in vivo by transforming growth factor-β: Remodeling of woven bone and lack of inhibition by indomethacinBone, 1990
- Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoidsMetabolic Bone Disease and Related Research, 1984